BRIEF-Lilly Sues Two Firms For Selling Unapproved Products Claiming To Contain Tirzepatide

Reuters
Apr 01
BRIEF-Lilly Sues Two Firms For Selling Unapproved Products Claiming To Contain Tirzepatide

April 1 (Reuters) - Eli Lilly and Co LLY.N:

  • ELI LILLY SUES STRIVE PHARMACY LLC, EMPOWER CLINIC SERVICES LLC FOR SELLING UNAPPROVED PRODUCTS CLAIMING TO CONTAIN TIRZEPATIDE

  • ELI LILLY: TO SEND ABOUT 50 CEASE AND DESIST LETTERS TO COMPOUNDERS AND TELEHEALTH FIRMS ASKING TO CONFIRM THEY HAVE CEASED MASS COMPOUNDING

Further company coverage: LLY.N

((Reuters.Briefs@thomsonreuters.com;;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10